MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Effects of Telerehabilitation on Balance, Gait, Functional Mobility, Physical Activity, Quality of Life, and Social Support Among Adults with Parkinson Disease: A Systematic Review

    P. Darbandsari, L. Pescatello, D. Piscitelli, J. Smith, C. Colon-Semenza (Storrs, USA)

    Objective: This systematic review examined the effect of telerehabilitation on balance, gait, functional mobility, physical activity, quality of life, and social support among adults living…
  • 2024 International Congress

    Impact of Community Boxing Program on Non-motor Symptoms in Individuals with Parkinson’s Disease

    M. Braitsch, S. Shearin, R. Querry, E. Perez (Richardson, USA)

    Objective: The purpose of this intervention was to assess the impact of boxing on non-motor symptoms (NMS) in PD. Background: ​​​​​​For persons with Parkinson’s Disease…
  • 2024 International Congress

    Loneliness Relates to Gait Over Other Features of Parkinsonism

    D. Gonzalez, R. Wilson, M. Tosin, C. Goetz (Chicago, USA)

    Objective: To assess the relationship between loneliness and facets of parkinsonism in community-based samples. Background: Loneliness increases the risk of mortality, dementia, depression, and motor…
  • 2024 International Congress

    Improving Neuropsychiatric Comorbidity in Geriatric Spinocerebellar Ataxia

    M. Le, B. Carr (Gainesville, USA)

    Objective: This study evaluates neuropsychiatric comorbidity in spinocerebellar ataxia (SCA) and highlights key aspects of management in the geriatric population. It discusses efficacy of neuropsychotropic…
  • 2024 International Congress

    eHealth Technologies for People with Parkinson’s: Acceptance & Implications

    J. Stuempel, V. Fleckenstein, J. Hohn, K. Steidel, C. Münte, D. Pedrosa (Marburg, Germany)

    Objective: To investigate the impact of eHealth on Parkinson's care, focusing on technology acceptance and examining ethical, legal, social, and medical aspects of wearables. Background:…
  • 2024 International Congress

    Improvement in Upright Stability subscale of mFARS with Vatiquinone Treatment in MOVE-FA: a Phase 3, Double-blind, Placebo-controlled Trial

    D. Lynch, A. Duquette, M. França Jr, S. Perlman, A. Durr, E. Bertini, A. Darling, K. Mathews, L. Schöls, A. Fournier, M. Delatycki, S. Subramony, R. Roxburgh, O. Zhang, C. Rummey, A. Salvucci, B. Yao, J. Cherry, L. Golden, T. Zesiewicz (Philadelphia, USA)

    Objective: Describe the results of vatiquinone on the Upright Stability Subscale (USS) from MOVE-FA (NCT04577352), the 72-week placebo-controlled phase 3 study of patients with Friedreich…
  • 2024 International Congress

    Reduced intestinal inflammation and increased levels of short-chain fatty acids thanks to an active lifestyle in Parkinson’s disease.

    NES. Chtioui, CHR. Duval, DAV. St-Pierre (Montreal, Canada)

    Objective: This study aimed to determine whether people with Parkinson’s disease (PD) with an active lifestyle had increased production of certain microbial metabolites such as…
  • 2024 International Congress

    Opicapone as Add-on to Levodopa in Parkinson’s Patients without Motor Complications: Preliminary Data from EPSILON

    J. Ferreira, O. Rascol, F. Stocchi, A. Antonini, J. Moreira, G. Castilla-Fernández, J. Rocha, J. Holenz, W. Poewe (Lisbon, Portugal)

    Objective: The EPSILON study aimed to explore the potential of opicapone (OPC) to enhance the clinical benefit of levodopa/dopa decarboxylase inhibitor (DDCi) in patients with…
  • 2024 International Congress

    Intrinsic Auricular Muscle Zone Stimulation for Moderate-to-Severe Parkinson’s Disease

    S. Brillman, A. Samiian, V. Sharma, S. Ertan, . öztop çakmak (Palo Alto, USA)

    Objective: To assess the effects of electrical stimulation of the Intrinsic Auricular Muscle Zone (IAMZ) on motor symptoms in patients with moderate-to-severe Parkinson’s disease (PD).…
  • 2024 International Congress

    GRoningen Early-PD Ambroxol Treatment (GREAT) Trial: A randomized, double-blind, placebo-controlled, single center trial with ambroxol in Parkinson patients with a GBA-mutation

    O. Siemeling, S. Slingerland, S. V/d Zee, T. van Laar (Groningen, Netherlands)

    Objective: To study the potential disease-modifying properties of ambroxol in PD patients with a GBA1 mutation Background: The most common genetic risk factor for Parkinson’s…
  • « Previous Page
  • 1
  • …
  • 101
  • 102
  • 103
  • 104
  • 105
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley